Deletion of this N-terminal region of Nurr1 produce a rather stable Nurr1 protein with full capabilities as transcription factor, accordingly Nurr1 Δ1–31 construct could be an excellent candidate for its use in genetic and cell therapeutic strategies for PD patients. This evidence concerns the gene NR4A2 and Parkinson disease.